Volume 28, Number 4—April 2022
Research
SARS-CoV-2 IgG Seroprevalence among Blood Donors as a Monitor of the COVID-19 Epidemic, Brazil
Figure 1

Figure 1. Temporal evolving cumulative severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence in HEMOMINAS Foundation blood donation centers in 7 cities of Minas Gerais, Brazil, March–December 2020. A) March; B) June; C) September; D) December. Data represent SARS-CoV-2 IgG seropositivity among persons eligible to donate blood. Scale bar represents cumulative proportion of SARS-CoV-2 IgG seropositivity per 100,000 population. Gov., Governador.
1These authors contributed equally to this article.